Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
Diabetes Care
|
May 31, 2020
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
Sue A Brown, Roy W Beck, Dan Raghinaru, et al.
Diabetes Technology & Therapeutics
|
October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes
Amy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Technology & Therapeutics
|
October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes
Catherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics
|
March 10, 2021
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System
Melissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, et al.
Hormone Research in Paediatrics
|
December 10, 2024
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Othmar Moser, Dessi Zaharieva, Peter Adolfsson, et al.
Diabetologia
|
December 9, 2024
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Othmar Moser, Dessi P Zaharieva, Peter Adolfsson, et al.
Diabetes Care
|
June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Sue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Care
|
December 16, 2025
Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals With Type 1 Diabetes
Marcela Moscoso-Vasquez, Laya Ekhlaspour, Sue A Brown, et al.
Diabetes Technology & Therapeutics
|
December 16, 2020
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes
Gregory P Forlenza, Bruce A Buckingham, Sue A Brown, et al.
Journal of Diabetes Science and Technology
|
July 1, 2025
Early Stages of Automated Insulin Delivery
Howard Zisser, Roman Hovorka, Ananda Basu, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
Diabetes Care
|
May 31, 2020
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
Sue A Brown, Roy W Beck, Dan Raghinaru, et al.
Diabetes Technology & Therapeutics
|
October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes
Amy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Technology & Therapeutics
|
October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes
Catherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics
|
March 10, 2021
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System
Melissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, et al.
Hormone Research in Paediatrics
|
December 10, 2024
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Othmar Moser, Dessi Zaharieva, Peter Adolfsson, et al.
Diabetologia
|
December 9, 2024
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Othmar Moser, Dessi P Zaharieva, Peter Adolfsson, et al.
Diabetes Care
|
June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Sue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Care
|
December 16, 2025
Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals With Type 1 Diabetes
Marcela Moscoso-Vasquez, Laya Ekhlaspour, Sue A Brown, et al.
Diabetes Technology & Therapeutics
|
December 16, 2020
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes
Gregory P Forlenza, Bruce A Buckingham, Sue A Brown, et al.
Journal of Diabetes Science and Technology
|
July 1, 2025
Early Stages of Automated Insulin Delivery
Howard Zisser, Roman Hovorka, Ananda Basu, et al.
Page
of 15